⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
DXCM News
DexCom, Inc.
Immunoassay Market Research, Strategies, Trends and Forecasts Report 2025 with Executive Guides and Impact of Artificial Intelligence - ResearchAndMarkets.com
businesswire.com
ALGN
AMZN
BDX
BIO
BMY
CDNS
CERN
CHKP
CLVS
CODX
CRSP
CYTK
DELL
DGX
DHR
DIS
DTC
DXCM
ENZ
EXAS
FSLR
GILD
GOOG
IDXX
ILMN
INCY
INTC
ISRG
JNJ
LULU
LUMX
MDLZ
MRNA
MSFT
MYL
NBIX
NCLH
NFLX
NVS
NVTA
ORCL
ORGO
OSIP
OTIS
PANW
PFE
PG
PGR
PPC
PRGO
QCOM
QGEN
QORV
QUID
REGN
ROCH
ROST
SGEN
SIRI
SNPS
SPLK
SRPT
SWKS
SYK
TCOM
TEAM
TEVA
TGT
TMO
TSLA
TXN
ULTA
UNH
VRTX
WBA
WDC
WEC
WFC
XRAY
XTRA
ZBRA
Shareholders of DexCom, Inc. (DXCM): Protect Your Rights Before December 26, 2025 - Contact Levi & Korsinsky
accessnewswire.com
DXCM
Dexcom Smart Basal Receives FDA Clearance Becoming the First and Only CGM-integrated Basal Insulin Dosing Optimizer for Type 2 Diabetes
businesswire.com
DXCM
Securities Lawsuit Alert: DexCom, Inc. (DXCM) - Contact Levi & Korsinsky Before December 26, 2025
accessnewswire.com
DXCM
Pomerantz LLP Files Securities Class Action Lawsuit Against DexCom, Inc. – DXCM
accessnewswire.com
DXCM
DXCM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
DXCM
Securities Class Action Lawsuit Filed Against DexCom, Inc. (DXCM) - Levi & Korsinsky Represents Shareholders
accessnewswire.com
DXCM
Securities Class Action Lawsuit Filed Against DexCom, Inc. (DXCM) - Levi & Korsinsky Represents Shareholders
accessnewswire.com
DXCM
December 26, 2025 Deadline: Join Class Action Lawsuit Against DexCom, Inc. (DXCM) - Contact Levi & Korsinsky
accessnewswire.com
DXCM
DXCM LAWSUIT ALERT: Levi & Korsinsky Notifies DexCom, Inc. Investors - Lead Plaintiff Deadline December 26, 2025
accessnewswire.com
DXCM